Safety and tolerance of Lacticaseibacillus paracasei N1115 in caesarean-born young children: a randomised, placebo-controlled trial
In: Beneficial MicrobesSearch for other papers by Z. Ren in
Current site
Google Scholar
Search for other papers by A. Zhao in
Current site
Google Scholar
Search for other papers by J. Zhang in
Current site
Google Scholar
Search for other papers by C. Yang in
Current site
Google Scholar
Search for other papers by W. Zhong in
Current site
Google Scholar
Search for other papers by S. Mao in
Current site
Google Scholar
Peking University Medical Science-Junlebao Dairy Joint Laboratory of Breast Milk Science and Life Health, Beijing 100191, China P.R.
Search for other papers by S. Wang in
Current site
Google Scholar
Peking University Medical Science-Junlebao Dairy Joint Laboratory of Breast Milk Science and Life Health, Beijing 100191, China P.R.
Search for other papers by Q. Yuan in
Current site
Google Scholar
Search for other papers by P. Wang in
Current site
Google Scholar
Peking University Medical Science-Junlebao Dairy Joint Laboratory of Breast Milk Science and Life Health, Beijing 100191, China P.R.
Search for other papers by Y. Zhang in
Current site
Google Scholar
The administration of probiotics may help to improve dysbiosis and related health problems in children delivered by caesarean section. However, the effects are strain specific, and safety combined tolerance are considered a priority. The aim of this study was to evaluate the safety and tolerance of Lacticaseibacillus paracasei N1115 in caesarean-born children aged 6-24 months via a randomised, placebo-controlled intervention study. In total, 101 children were included and randomised to receive either a sachet of L. paracasei N1115 (2×1010 cfu/g, 2 g/day) or placebo (maltodextrin, 2 g/day) per day for 12 weeks. Anthropometric parameters were measured by trained nurses, and defecation characteristics, gastrointestinal symptoms, (serious) adverse events ((s)AEs), crying patterns and lifestyle behaviours were recorded by parents or guardians. Neurocognitive development was assessed by the Ages and Stages Questionnaires-3 (ASQ-3) before and after the intervention. The only difference between groups regarding defecation characteristics was a significant treatment × time effect on stool frequency (P=0.007), as the number of defecations was significantly higher in the probiotic group (around 1.2-1.3 times/day) than in the placebo group (around 1.0 times/day) in the later intervention period (P=0.035 at week 9; P=0.048 at week 10; P=0.026 at week 12). The use of L. paracasei N1115 also reduced the incidence rate of constipation (Incidence rate ratio (IRR): 0.120; 95% confidence interval (CI): 0.015, 0.967; P=0.046) and abdominal pain (IRR: 0.562; 95% CI: 0.358, 0.882; P=0.012). Changes in anthropometric parameters, including weight, height and head circumference, did not differ significantly between groups, nor did measures of crying, sleep, outdoor activity, temper, appetite or the ASQ-3 scores. No adverse events associated with consumption of the probiotic were reported. Thus, the administration of L. paracasei N1115 is safe and well-tolerated in caesarean-born children aged 6-24 months. Furthermore, it may ameliorate gastrointestinal function to some extent.
-
Athalye-Jape, G., Rao, S. and Patole, S., 2016. Lactobacillus reuteri DSM 17938 as a probiotic for preterm neonates: a strain-specific systematic review. Journal of Parenteral and Enteral Nutrition 40: 783-794. https://doi.org/10.1177/0148607115588113
-
Azpiroz, F. and Malagelada, J.R., 2005. Abdominal bloating. Gastroenterology 129: 1060-1078. https://doi.org/10.1053/j.gastro.2005.06.062
-
Baldassarre, M.E., Di Mauro, A., Cintoli, A., Mincarone, G., S., T. and Laforgia, N., 2017. Non-communicable chronic diseases: the role of neonatal characteristics. Iranian Journal of Pediatrics 27: e9322. https://doi.org/10.5812/ijp.9322
-
Baldassarre, M.E., Di Mauro, A., Tafuri, S., Rizzo, V., Gallone, M.S., Mastromarino, P., Capobianco, D., Laghi, L., Zhu, C., Capozza, M. and Laforgia, N., 2018a. Effectiveness and safety of a probiotic-mixture for the treatment of infantile colic: a double-blind, randomized, placebo-controlled clinical trial with fecal real-time PCR and NMR-based metabolomics analysis. Nutrients 10: 195. https://doi.org/10.3390/nu10020195
-
Baldassarre, M.E., Palladino, V., Amoruso, A., Pindinelli, S., Mastromarino, P., Fanelli, M., Di Mauro, A. and Laforgia, N., 2018b. Rationale of probiotic supplementation during pregnancy and neonatal period. Nutrients 10: 1693. https://doi.org/10.3390/nu10111693
-
Bekem, Ö., Günay, İ., Çelik, F. and Apa, H., 2021. Interaction of functional gastrointestinal disorders with postpartum conditions related to mother and baby. Turkish Journal of Pediatrics 63: 461-470. https://doi.org/10.24953/turkjped.2021.03.013
-
Boerma, T., Ronsmans, C., Melesse, D.Y., Barros, A.J.D., Barros, F.C., Juan, L., Moller, A.B., Say, L., Hosseinpoor, A.R., Yi, M., de Lyra Rabello Neto, D. and Temmerman, M., 2018. Global epidemiology of use of and disparities in caesarean sections. The Lancet 392: 1341-1348. https://doi.org/10.1016/s0140-6736(18)31928-7
-
Braegger, C., Chmielewska, A., Decsi, T., Kolacek, S., Mihatsch, W., Moreno, L., Piescik, M., Puntis, J., Shamir, R., Szajewska, H., Turck, D. and van Goudoever, J., 2011. Supplementation of infant formula with probiotics and/or prebiotics: a systematic review and comment by the ESPGHAN committee on nutrition. Journal of Pediatric Gastroenterology and Nutrition 52: 238-250. https://doi.org/10.1097/MPG.0b013e3181fb9e80
-
Callaway, E., 2019. C-section babies are missing key microbes. Nature, 18 September 2019. https://doi.org/10.1038/d41586-019-02807-x
-
Cao, Y., Zhang, J., Zheng, Z., Mei, X., Wang, S., Zhu, H. and Yang, N., 2018. Therapeutic Effect of Lactobacillus paracasei N1115 fermented milk in constipated mice. Food Science 39: 185-191. https://doi.org/10.7506/spkx1002-6630-201801028
-
Coccorullo, P., Strisciuglio, C., Martinelli, M., Miele, E., Greco, L. and Staiano, A., 2010. Lactobacillus reuteri (DSM 17938) in infants with functional chronic constipation: a double-blind, randomized, placebo-controlled study. Journal of Pediatrics 157: 598-602. https://doi.org/10.1016/j.jpeds.2010.04.066
-
Conta, G., Del Chierico, F., Reddel, S., Marini, F., Sciubba, F., Capuani, G., Tomassini, A., Di Cocco, M.E., Laforgia, N., Baldassarre, M.E., Putignani, L. and Miccheli, A., 2021. Longitudinal multi-omics study of a mother-infant dyad from breastfeeding to weaning: an individualized approach to understand the interactions among diet, fecal metabolome and microbiota composition. Frontiers in Molecular Bioscience 8: 688440. https://doi.org/10.3389/fmolb.2021.688440
-
Crellin, D.J., Harrison, D., Hutchinson, A., Schuster, T., Santamaria, N. and Babl, F.E., 2017. Procedural Pain Scale Evaluation (PROPoSE) study: protocol for an evaluation of the psychometric properties of behavioural pain scales for the assessment of procedural pain in infants and children aged 6-42 months. BMJ Open 7: e016225. https://doi.org/10.1136/bmjopen-2017-016225
-
Cryan, J.F., O’Riordan, K.J., Cowan, C.S.M., Sandhu, K.V., Bastiaanssen, T.F.S., Boehme, M., Codagnone, M.G., Cussotto, S., Fulling, C., Golubeva, A.V., Guzzetta, K.E., Jaggar, M., Long-Smith, C.M., Lyte, J. M., Martin, J.A., Molinero-Perez, A., Moloney, G., Morelli, E., Morillas, E., O’Connor, R., Cruz-Pereira, J.S., Peterson, V.L., Rea, K., Ritz, N.L., Sherwin, E., Spichak, S., Teichman, E.M., van de Wouw, M., Ventura-Silva, A.P., Wallace-Fitzsimons, S.E., Hyland, N., Clarke, G. and Dinan, T.G., 2019. The microbiota-gut-brain axis. Physiological Reviews 99: 1877-2013. https://doi.org/10.1152/physrev.00018.2018
-
Davis, E.C., Dinsmoor, A.M., Wang, M. and Donovan, S.M., 2020. Microbiome composition in pediatric populations from birth to adolescence: impact of diet and prebiotic and probiotic interventions. Digestive Diseases and Sciences 65: 706-722. https://doi.org/10.1007/s10620-020-06092-x
-
Dimidi, E., Christodoulides, S., Scott, S.M. and Whelan, K., 2017. Mechanisms of action of probiotics and the gastrointestinal microbiota on gut motility and constipation. Advances in Nutrition 8: 484-494. https://doi.org/10.3945/an.116.014407
-
Food and Agriculture Organization of the United Nations/World Health Organization (FAO/WHO), 2002. Guidelines for the evaluation of probiotics in food. Report of a Joint FAO/WHO working group on drafting guidelines for the evaluation of probiotics in food. Available at: http://tinyurl.com/zdbrkeg.
-
Feng, L., Wang, H., Wang, S., Li, X. and Zhu, H., 2017. The study of the improvement of intestinal health by instant type Lactobacillus power. Food Research and Development 38: 34-37. https://doi.org/10.3969/j.issn.1005-6521.2017.09.008
-
Francavilla, R., Cristofori, F., Tripaldi, M.E. and Indrio, F., 2018. Intervention for dysbiosis in children born by c-section. Annals of Nutrition and Metabolism 73 Suppl. 3: 33-39. https://doi.org/10.1159/000490847
-
Francavilla, R., Lionetti, E., Castellaneta, S., Ciruzzi, F., Indrio, F., Masciale, A., Fontana, C., La Rosa, M.M., Cavallo, L. and Francavilla, A., 2012. Randomised clinical trial: Lactobacillus reuteri DSM 17938 vs. placebo in children with acute diarrhoea--a double-blind study. Alimentary Pharmacology and Therapeutics 36: 363-369. https://doi.org/10.1111/j.1365-2036.2012.05180.x
-
Gerasimov, S., Gantzel, J., Dementieva, N., Schevchenko, O., Tsitsura, O., Guta, N., Bobyk, V. and Kaprus, V., 2018. Role of Lactobacillus rhamnosus (FloraActive™) 19070-2 and Lactobacillus reuteri (FloraActive™) 12246 in infant colic: a randomized dietary study. Nutrients 10: 1975. https://doi.org/10.3390/nu10121975
-
Gil-Campos, M., López, M., Rodriguez-Benítez, M.V., Romero, J., Roncero, I., Linares, M.D., Maldonado, J., López-Huertas, E., Berwind, R., Ritzenthaler, K.L., Navas, V., Sierra, C., Sempere, L., Geerlings, A., Maldonado-Lobón, J.A., Valero, A.D., Lara-Villoslada, F. and Olivares, M., 2012. Lactobacillus fermentum CECT 5716 is safe and well tolerated in infants of 1-6 months of age: a randomized controlled trial. Pharmacological Research 65: 231-238. https://doi.org/10.1016/j.phrs.2011.11.016
-
Gustin, J., Gibb, R., Kenneally, D., Kutay, B., Waimin Siu, S. and Roe, D., 2018. Characterizing exclusively breastfed infant stool via a novel infant stool scale. Journal of Parenteral and Enteral Nutrition 42 Suppl. 1: S5-S11. https://doi.org/10.1002/jpen.1468
-
Hashemi, A., Villa, C.R. and Comelli, E.M., 2016. Probiotics in early life: a preventative and treatment approach. Food and Function 7: 1752-1768. https://doi.org/10.1039/c5fo01148e
-
Hoang, D.M., Levy, E.I. and Vandenplas, Y., 2021. The impact of caesarean section on the infant gut microbiome. Acta Paediatrica 110: 60-67. https://doi.org/10.1111/apa.15501
-
Iyer, R. and Nallasamy, K., 2018. Child with abdominal pain. Indian Journal of Pediatrics 85: 71-76. https://doi.org/10.1007/s12098-017-2447-5
-
Kong, X.J., Liu, K., Zhuang, P., Tian, R., Liu, S., Clairmont, C., Lin, X., Sherman, H., Zhu, J., Wang, Y., Fong, M., Li, A., Wang, B.K., Wang, J., Yu, Z., Shen, C., Cui, X., Cao, H., Du, T., Wan, G. and Cao, X., 2021a. The effects of Limosilactobacillus reuteri LR-99 supplementation on body mass index, social communication, fine motor function, and gut microbiome composition in individuals with Prader-Willi syndrome: a randomized double-blinded placebo-controlled trial. Probiotics and Antimicrobial Proteins 13: 1508-1520. https://doi.org/10.1007/s12602-021-09800-9
-
Kong, X.J., Wan, G., Tian, R., Liu, S., Liu, K., Clairmont, C., Lin, X., Zhang, X., Sherman, H., Zhu, J., Wang, Y., Fong, M., Li, A., Wang, B.K., Wang, J., Liu, J., Yu, Z., Shen, C., Cui, X., Cao, H., Du, T. and Cao, X., 2021b. The effects of probiotic supplementation on anthropometric growth and gut microbiota composition in patients with Prader-Willi syndrome: a randomized double-blinded placebo-controlled trial. Frontiers in Nutrition 8: 587974. https://doi.org/10.3389/fnut.2021.587974
-
Koppen, I.J.N., Velasco-Benitez, C.A., Benninga, M.A., Di Lorenzo, C. and Saps, M., 2016. Using the Bristol stool scale and parental report of stool consistency as Part of the Rome III criteria for functional constipation in infants and toddlers. Journal of Pediatrics 177: 44-48.e41. https://doi.org/10.1016/j.jpeds.2016.06.055
-
Korpela, K. and de Vos, W.M., 2018. Early life colonization of the human gut: microbes matter everywhere. Current Opinion in Microbiology 44: 70-78. https://doi.org/10.1016/j.mib.2018.06.003
-
Liu, Y., Tian, X., He, B., Hoang, T.K., Taylor, C.M., Blanchard, E., Freeborn, J., Park, S., Luo, M., Couturier, J., Tran, D.Q., Roos, S., Wu, G. and Rhoads, J.M., 2019. Lactobacillus reuteri DSM 17938 feeding of healthy newborn mice regulates immune responses while modulating gut microbiota and boosting beneficial metabolites. American Journal of Physiology – Gastrointestinal and Liver Physiology 317: G824-g838. https://doi.org/10.1152/ajpgi.00107.2019
-
Martoni, C.J., Srivastava, S. and Leyer, G.J., 2020. Lactobacillus acidophilus DDS-1 and Bifidobacterium lactis UABla-12 improve abdominal pain severity and symptomology in irritable bowel syndrome: randomized controlled trial. Nutrients 12: 363. https://doi.org/10.3390/nu12020363
-
McFarland, L.V., Evans, C.T. and Goldstein, E.J.C., 2018. Strain-specificity and disease-specificity of probiotic efficacy: a systematic review and meta-analysis. Frontiers in Medicine 5: 124. https://doi.org/10.3389/fmed.2018.00124
-
Miller, J.E., Goldacre, R., Moore, H.C., Zeltzer, J., Knight, M., Morris, C., Nowell, S., Wood, R., Carter, K.W., Fathima, P., de Klerk, N., Strunk, T., Li, J., Nassar, N., Pedersen, L.H. and Burgner, D.P., 2020. Mode of birth and risk of infection-related hospitalisation in childhood: A population cohort study of 7.17 million births from 4 high-income countries. PLoS Medicine 17: e1003429. https://doi.org/10.1371/journal.pmed.1003429
-
Moya-Pérez, A., Luczynski, P., Renes, I.B., Wang, S., Borre, Y., Anthony Ryan, C., Knol, J., Stanton, C., Dinan, T.G. and Cryan, J.F., 2017. Intervention strategies for cesarean section-induced alterations in the microbiota-gut-brain axis. Nutrition Reviews 75: 225-240. https://doi.org/10.1093/nutrit/nuw069
-
Mugambi, M.N., Musekiwa, A., Lombard, M., Young, T. and Blaauw, R., 2012. Synbiotics, probiotics or prebiotics in infant formula for full term infants: a systematic review. Nutrition Journal 11: 81. https://doi.org/10.1186/1475-2891-11-81
-
Pan, K., Zhang, C. and Tian, J., 2021. The effects of different modes of delivery on the structure and predicted function of intestinal microbiota in neonates and early infants. Polish Journal of Microbiology 70: 45-55. https://doi.org/10.33073/pjm-2021-002
-
Pu, F., Guo, Y., Li, M., Zhu, H., Wang, S., Shen, X., He, M., Huang, C. and He, F., 2017. Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: a randomized controlled open-label trial. Clinical Interventions in Aging 12: 1223-1231. https://doi.org/10.2147/cia.S141518
-
Quigley, E.M., 2011. Microflora modulation of motility. Journal of Neurogastroenterology and Motility 17: 140-147. https://doi.org/10.5056/jnm.2011.17.2.140
-
Salvatore, S., Pensabene, L., Borrelli, O., Saps, M., Thapar, N., Concolino, D., Staiano, A. and Vandenplas, Y., 2018. Mind the gut: probiotics in paediatric neurogastroenterology. Beneficial Microbes 9: 883-898. https://doi.org/10.3920/bm2018.0013
-
Sestito, S., D’Auria, E., Baldassarre, M.E., Salvatore, S., Tallarico, V., Stefanelli, E., Tarsitano, F., Concolino, D. and Pensabene, L., 2020. The role of prebiotics and probiotics in prevention of allergic diseases in infants. Frontiers in Pediatrics 8: 583946. https://doi.org/10.3389/fped.2020.583946
-
Squires, J., Twombly, E., Bricker, D. and Potter, L., 2009. ASQ-3 user’s guide. Paul H Brookes Publishing Co., Baltimore, MD, USA.
'ASQ-3 user’s guide', ().
-
Szajewska, H. and Chmielewska, A., 2013. Growth of infants fed formula supplemented with Bifidobacterium lactis Bb12 or Lactobacillus GG: a systematic review of randomized controlled trials. BMC Pediatrics 13: 185. https://doi.org/10.1186/1471-2431-13-185
-
Wang, S., Xun, Y., Ahern, G.J., Feng, L., Zhang, D., Xue, Y., Ross, R.P., Doolan, A.M., Stanton, C. and Zhu, H., 2021. A randomized, double blind, parallel, placebo-controlled study to investigate the efficacy of Lactobacillus paracasei N1115 in gut development of young children. Food Science and Nutrition 9: 6020-6030. https://doi.org/10.1002/fsn3.2533
-
Wang, S., Yan, F., He, F. and Zhu, H., 2016. Effects of Lactobacillus paracasei N1115 on intestinal development in neonatal mice. Acta Nutrimenta Sinica 38: 71-74. https://doi.org/10.13325/j.cnki.acta.nutr.sin.2016.01.015
-
Wang, S., Zhu, H., He, F., Luo, Y., Kang, Z., Lu, C., Feng, L., Lu, X., Xue, Y. and Wang, H., 2014. Whole genome sequence of the probiotic strain Lactobacillus paracasei N1115, isolated from traditional Chinese fermented milk. Genome Announcements 2: e00059-00014. https://doi.org/10.1128/genomeA.00059-14
-
Xun, Y., Zhu, H., Feng, L., Zhang, D., Xue, Y. and Wang, S., 2020. Effects of Lactobacillus paracasei N1115 on intestinal health in infants born by caesarean section. Acta Nutrimenta Sinica 42: 338-343. https://doi.org/10.3969/j.issn.0512-7955.2020.04.006
-
Yao, F., Jia, R., Huang, H., Yu, Y., Mei, L., Bai, L., Ding, Y. and Zheng, P., 2019. Effect of Lactobacillus paracasei N1115 and fructooligosaccharides in nonalcoholic fatty liver disease. Archives of Medical Science 15: 1336-1344. https://doi.org/10.5114/aoms.2019.86611
-
Zeevenhooven, J., Koppen, I.J. and Benninga, M.A., 2017. The New Rome IV criteria for functional gastrointestinal disorders in infants and toddlers. Pediatric Gastroenterology, Hepatology and Nutrition 20: 1-13. https://doi.org/10.5223/pghn.2017.20.1.1
-
Zhang, Y., Pu, F., Cheng, R., Guo, J., Shen, X., Wang, S., Zhu, H., Zhang, X., Cheng, G., Li, M. and He, F., 2020. Effect of heat-inactivated Lactobacillus paracasei N1115 on microbiota and gut-brain axis related molecules. Bioscience of Microbiota, Food and Health 39: 89-99. https://doi.org/10.12938/bmfh.2019-025
Supplementary Materials
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 0 | 0 | 0 |
| Full Text Views | 723 | 229 | 24 |
| PDF Views & Downloads | 512 | 203 | 15 |
Safety and tolerance of Lacticaseibacillus paracasei N1115 in caesarean-born young children: a randomised, placebo-controlled trial
In: Beneficial MicrobesSearch for other papers by Z. Ren in
Current site
Google Scholar
PubMed
Search for other papers by A. Zhao in
Current site
Google Scholar
PubMed
Search for other papers by J. Zhang in
Current site
Google Scholar
PubMed
Search for other papers by C. Yang in
Current site
Google Scholar
PubMed
Search for other papers by W. Zhong in
Current site
Google Scholar
PubMed
Search for other papers by S. Mao in
Current site
Google Scholar
PubMed
Peking University Medical Science-Junlebao Dairy Joint Laboratory of Breast Milk Science and Life Health, Beijing 100191, China P.R.
Search for other papers by S. Wang in
Current site
Google Scholar
PubMed
Peking University Medical Science-Junlebao Dairy Joint Laboratory of Breast Milk Science and Life Health, Beijing 100191, China P.R.
Search for other papers by Q. Yuan in
Current site
Google Scholar
PubMed
Search for other papers by P. Wang in
Current site
Google Scholar
PubMed
Peking University Medical Science-Junlebao Dairy Joint Laboratory of Breast Milk Science and Life Health, Beijing 100191, China P.R.
Search for other papers by Y. Zhang in
Current site
Google Scholar
PubMed
The administration of probiotics may help to improve dysbiosis and related health problems in children delivered by caesarean section. However, the effects are strain specific, and safety combined tolerance are considered a priority. The aim of this study was to evaluate the safety and tolerance of Lacticaseibacillus paracasei N1115 in caesarean-born children aged 6-24 months via a randomised, placebo-controlled intervention study. In total, 101 children were included and randomised to receive either a sachet of L. paracasei N1115 (2×1010 cfu/g, 2 g/day) or placebo (maltodextrin, 2 g/day) per day for 12 weeks. Anthropometric parameters were measured by trained nurses, and defecation characteristics, gastrointestinal symptoms, (serious) adverse events ((s)AEs), crying patterns and lifestyle behaviours were recorded by parents or guardians. Neurocognitive development was assessed by the Ages and Stages Questionnaires-3 (ASQ-3) before and after the intervention. The only difference between groups regarding defecation characteristics was a significant treatment × time effect on stool frequency (P=0.007), as the number of defecations was significantly higher in the probiotic group (around 1.2-1.3 times/day) than in the placebo group (around 1.0 times/day) in the later intervention period (P=0.035 at week 9; P=0.048 at week 10; P=0.026 at week 12). The use of L. paracasei N1115 also reduced the incidence rate of constipation (Incidence rate ratio (IRR): 0.120; 95% confidence interval (CI): 0.015, 0.967; P=0.046) and abdominal pain (IRR: 0.562; 95% CI: 0.358, 0.882; P=0.012). Changes in anthropometric parameters, including weight, height and head circumference, did not differ significantly between groups, nor did measures of crying, sleep, outdoor activity, temper, appetite or the ASQ-3 scores. No adverse events associated with consumption of the probiotic were reported. Thus, the administration of L. paracasei N1115 is safe and well-tolerated in caesarean-born children aged 6-24 months. Furthermore, it may ameliorate gastrointestinal function to some extent.
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 0 | 0 | 0 |
| Full Text Views | 723 | 229 | 24 |
| PDF Views & Downloads | 512 | 203 | 15 |
